Mutlu Saglam
Research Subjects
Mutlu Saglam has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Alper Sonmez
Department of Endocrinology and Metabolism, Ankara Güven Hospital, Ankara, Turkey
3 shared publications - Abdulgaffar Vural
Department of Nephrology, Gülhane School of Medicine, Etlik, 06018, Ankara, Turkey
2 shared publications - Mahmut Ilker Yilmaz
Department of Nephrology, Gülhane School of Medicine, Ankara, Turkey
2 shared publications Bilal Battal
Department of Radiology Gulhane School of Medicine, Ankara, Turkey
1 shared publication- Carmine Zoccali
Institute of Molecular Biology and Genetics (Biogem), Ariano Irpino, Italy
1 shared publication - Cem Haymana
Department of Endocrinology and Metabolism, University of Health Sciences, Gülhane Training and Research Hospital, Ankara, Turkey
1 shared publication
Latest Publications
- Open Access
- 16 April 2015
- Published by Springer Nature in Lipids in Health and Disease
- Vol. 14 (1) , 1-8
The role of plasma triglyceride/high-density lipoprotein cholesterol ratio to predict cardiovascular outcomes in chronic kidney disease
Cardiovascular disease (CVD) risk is substantially increased in subjects with chronic kidney disease (CKD). The Triglycerides (TG) to High-Density Lipoprotein Cholesterol (HDL-C) ratio is an indirect measure of insulin resistance and an independent predictor of cardiovascular risk. No study to date has been performed to evaluate whether the TG/HDL-C ratio predicts CVD risk in patients with CKD. A total of 197 patients (age 53 ± 12 years) with CKD Stages 1 to 5, were enrolled in this longitudinal, observational, retrospective study. TG/HDL-C ratio, HOMA-IR indexes, serum asymmetric dimethyl arginine (ADMA), high sensitivity C-reactive protein (CRP), parathyroid hormone (PTH), calcium, phosphorous, estimated glomerular filtration rate (eGFR), and albumin levels were measured. Flow mediated vasodilatation (FMD) of the brachial artery was assessed by using high-resolution ultrasonography. A total of 11 cardiovascular (CV) deaths and 43 nonfatal CV events were registered in a mean follow-up period of 30 (range 9 to 35) months. Subjects with TG/HDL-C ratios above the median values (>3.29) had significantly higher plasma ADMA, PTH, and phosphorous levels (p = 0.04, p = 0.02, p = 0.01 respectively) and lower eGFR and FMD values (p = 0.03, p < 0.001 respectively). The TG/HDL-C ratio was an independent determinant of FMD (β = −0.25 p = 0.02) along with TG, HDL-C, hsCRP, serum albumin, phosphate levels, systolic blood pressure, PTH, eGFR and the presence of diabetes mellitus. The TG/HDL-C ratio was also a significant independent determinant of cardiovascular outcomes [HR: 1.36 (1.11-1.67) (p = 0.003)] along with plasma ADMA levels [HR: 1.31 (1.13-1.52) (p < 0.001)] and a history of diabetes mellitus [HR: 4.82 (2.80-8.37) (p < 0.001)]. This study demonstrates that the elevated TG/HDL-C ratio predicts poor CVD outcome in subjects with CKD. Being a simple, inexpensive, and reproducible marker of CVD risk, the TG/HDL-C ratio may emerge as a novel and reliable indicator among the many well-established markers of CVD risk in CKD. Clinical trial registration number and date: NCT02113462/10-04-2014.
- 16 April 2015
- Published by Springer Nature in Lipids in Health and Disease
- Vol. 14 (1) , 1-8
Open AccessThe role of plasma triglyceride/high-density lipoprotein cholesterol ratio to predict cardiovascular outcomes in chronic kidney disease
Cardiovascular disease (CVD) risk is substantially increased in subjects with chronic kidney disease (CKD). The Triglycerides (TG) to High-Density Lipoprotein Cholesterol (HDL-C) ratio is an indirect measure of insulin resistance and an independent predictor of cardiovascular risk. No study to date has been performed to evaluate whether the TG/HDL-C ratio predicts CVD risk in patients with CKD. A total of 197 patients (age 53 ± 12 years) with CKD Stages 1 to 5, were enrolled in this longitudinal, observational, retrospective study. TG/HDL-C ratio, HOMA-IR indexes, serum asymmetric dimethyl arginine (ADMA), high sensitivity C-reactive protein (CRP), parathyroid hormone (PTH), calcium, phosphorous, estimated glomerular filtration rate (eGFR), and albumin levels were measured. Flow mediated vasodilatation (FMD) of the brachial artery was assessed by using high-resolution ultrasonography. A total of 11 cardiovascular (CV) deaths and 43 nonfatal CV events were registered in a mean follow-up period of 30 (range 9 to 35) months. Subjects with TG/HDL-C ratios above the median values (>3.29) had significantly higher plasma ADMA, PTH, and phosphorous levels (p = 0.04, p = 0.02, p = 0.01 respectively) and lower eGFR and FMD values (p = 0.03, p < 0.001 respectively). The TG/HDL-C ratio was an independent determinant of FMD (β = −0.25 p = 0.02) along with TG, HDL-C, hsCRP, serum albumin, phosphate levels, systolic blood pressure, PTH, eGFR and the presence of diabetes mellitus. The TG/HDL-C ratio was also a significant independent determinant of cardiovascular outcomes [HR: 1.36 (1.11-1.67) (p = 0.003)] along with plasma ADMA levels [HR: 1.31 (1.13-1.52) (p < 0.001)] and a history of diabetes mellitus [HR: 4.82 (2.80-8.37) (p < 0.001)]. This study demonstrates that the elevated TG/HDL-C ratio predicts poor CVD outcome in subjects with CKD. Being a simple, inexpensive, and reproducible marker of CVD risk, the TG/HDL-C ratio may emerge as a novel and reliable indicator among the many well-established markers of CVD risk in CKD. Clinical trial registration number and date: NCT02113462/10-04-2014.
- 1 June 2009
- Published by Elsevier in Kidney International
- Vol. 75 (12) , 1316-1321
Hemoglobin is inversely related to flow-mediated dilatation in chronic kidney disease
- 1 June 2009
- Published by Elsevier in Kidney International
- Vol. 75 (12) , 1316-1321
Hemoglobin is inversely related to flow-mediated dilatation in chronic kidney disease
- 1 March 2009
- Vol. 15 (1) , 39-42
A case of pancreatic Burkitt lymphoma: radiological findings.
Burkitt lymphoma predominantly involving the pancreas is very rare. There is no specific clinical, laboratory, or radiological sign of the disease. Thus, the diagnosis, especially of focal involvement, is usually difficult. We here report ultrasonography, computed tomography and magnetic resonance imaging findings of primary pancreatic Burkitt lymphoma in a case with unusual radiological presentation.
- 1 March 2009
- Vol. 15 (1) , 39-42
A case of pancreatic Burkitt lymphoma: radiological findings.
Burkitt lymphoma predominantly involving the pancreas is very rare. There is no specific clinical, laboratory, or radiological sign of the disease. Thus, the diagnosis, especially of focal involvement, is usually difficult. We here report ultrasonography, computed tomography and magnetic resonance imaging findings of primary pancreatic Burkitt lymphoma in a case with unusual radiological presentation.
- 1 February 2008
- Published by Wiley in Journal of Ultrasound in Medicine
- Vol. 27 (2) , 209-214
Effect of Hyperbaric Oxygen on Flow-Mediated Vasodilation
Objective The purpose of this study was to investigate the effect of hyperbaric oxygen (HBO) treatment on flow-mediated vasodilation (FMD) by ultrasound examination. Methods We studied 14 young pa...
- 1 February 2008
- Published by Wiley in Journal of Ultrasound in Medicine
- Vol. 27 (2) , 209-214
Effect of Hyperbaric Oxygen on Flow-Mediated Vasodilation
Objective The purpose of this study was to investigate the effect of hyperbaric oxygen (HBO) treatment on flow-mediated vasodilation (FMD) by ultrasound examination. Methods We studied 14 young pa...
- 1 December 2004
- Published by Elsevier in European Journal of Radiology
- Vol. 52 (3) , 329-334
Transrectal ultrasound-guided transperineal and transrectal management of seminal vesicle abscesses
- 1 December 2004
- Published by Elsevier in European Journal of Radiology
- Vol. 52 (3) , 329-334
Transrectal ultrasound-guided transperineal and transrectal management of seminal vesicle abscesses